Testicular adrenal rest tumours in salt wasting congenital adrenal hyperplasia (in vivo and in vitro studies). 2005

Jean Pierre Bercovici, and Jean Fiet, and Laurence Gibault, and Alain Volant, and Jean Hervé Abalain, and Hervé Henri Floch, and Emmanuel Sonnet, and Georges Fournier
Department of Endocrinology, Université de Bretagne Occidentale (UBO), 29200 Brest, France.

We describe the case of a 20-year-old patient with salt-wasting congenital adrenal hyperplasia (CAH) related to 21-hydroxylase deficiency. Bilateral craggy testicular tumours were found, requiring histological evaluation. Prior to the surgical procedure, the patient was treated with dexamethasone (he presented cortisol deficiency) and was stimulated with ACTH. High levels of 11beta-OH steroids measured in the gonadal vein, compared with peripheral blood samples suggested the presence of adrenal rests. Incubation of the tumours (which could not be differentiated histologically, from Leydig tissue), with radioactive steroid precursors was carried out. The results revealed the testicular tumours were of adrenal tissue origin, associated with 21-hydroxylase deficiency. The patient's non-compliance to glucocorticoid treatment was the main cause of his hypogonadotropic hypogonadism.

UI MeSH Term Description Entries
D007006 Hypogonadism Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism). Hypergonadotropic Hypogonadism,Hypogonadism, Isolated Hypogonadotropic,Hypogonadotropic Hypogonadism,Hypogonadism, Hypergonadotropic,Hypogonadism, Hypogonadotropic
D007265 Inhibins Glycoproteins that inhibit pituitary FOLLICLE STIMULATING HORMONE secretion. Inhibins are secreted by the Sertoli cells of the testes, the granulosa cells of the ovarian follicles, the placenta, and other tissues. Inhibins and ACTIVINS are modulators of FOLLICLE STIMULATING HORMONE secretions; both groups belong to the TGF-beta superfamily, as the TRANSFORMING GROWTH FACTOR BETA. Inhibins consist of a disulfide-linked heterodimer with a unique alpha linked to either a beta A or a beta B subunit to form inhibin A or inhibin B, respectively Female Inhibin,Inhibin,Inhibin-F,Inhibins, Female,Inhibins, Testicular,Ovarian Inhibin,Testicular Inhibin,Female Inhibins,Inhibin F,Inhibin, Female,Inhibin, Ovarian,Inhibin, Testicular,Testicular Inhibins
D007984 Leydig Cell Tumor Gonadal interstitial or stromal cell neoplasm composed of only LEYDIG CELLS. These tumors may produce one or more of the steroid hormones such as ANDROGENS; ESTROGENS; and CORTICOSTEROIDS. Clinical symptoms include testicular swelling, GYNECOMASTIA, sexual precocity in children, or virilization (VIRILISM) in females. Interstitial Cell Tumor,Interstitial Cell Tumors,Tumor, Interstitial Cell,Tumor, Leydig Cell,Tumors, Interstitial Cell
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D008297 Male Males
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis

Related Publications

Jean Pierre Bercovici, and Jean Fiet, and Laurence Gibault, and Alain Volant, and Jean Hervé Abalain, and Hervé Henri Floch, and Emmanuel Sonnet, and Georges Fournier
January 2009, International journal of pediatric endocrinology,
Jean Pierre Bercovici, and Jean Fiet, and Laurence Gibault, and Alain Volant, and Jean Hervé Abalain, and Hervé Henri Floch, and Emmanuel Sonnet, and Georges Fournier
April 2009, Best practice & research. Clinical endocrinology & metabolism,
Jean Pierre Bercovici, and Jean Fiet, and Laurence Gibault, and Alain Volant, and Jean Hervé Abalain, and Hervé Henri Floch, and Emmanuel Sonnet, and Georges Fournier
May 2010, The Journal of clinical endocrinology and metabolism,
Jean Pierre Bercovici, and Jean Fiet, and Laurence Gibault, and Alain Volant, and Jean Hervé Abalain, and Hervé Henri Floch, and Emmanuel Sonnet, and Georges Fournier
January 2015, Endocrinology, diabetes & metabolism case reports,
Jean Pierre Bercovici, and Jean Fiet, and Laurence Gibault, and Alain Volant, and Jean Hervé Abalain, and Hervé Henri Floch, and Emmanuel Sonnet, and Georges Fournier
November 2022, BJR case reports,
Jean Pierre Bercovici, and Jean Fiet, and Laurence Gibault, and Alain Volant, and Jean Hervé Abalain, and Hervé Henri Floch, and Emmanuel Sonnet, and Georges Fournier
December 2007, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Jean Pierre Bercovici, and Jean Fiet, and Laurence Gibault, and Alain Volant, and Jean Hervé Abalain, and Hervé Henri Floch, and Emmanuel Sonnet, and Georges Fournier
January 2014, Hormone research in paediatrics,
Jean Pierre Bercovici, and Jean Fiet, and Laurence Gibault, and Alain Volant, and Jean Hervé Abalain, and Hervé Henri Floch, and Emmanuel Sonnet, and Georges Fournier
February 2022, Ultrasound (Leeds, England),
Jean Pierre Bercovici, and Jean Fiet, and Laurence Gibault, and Alain Volant, and Jean Hervé Abalain, and Hervé Henri Floch, and Emmanuel Sonnet, and Georges Fournier
July 2003, European radiology,
Jean Pierre Bercovici, and Jean Fiet, and Laurence Gibault, and Alain Volant, and Jean Hervé Abalain, and Hervé Henri Floch, and Emmanuel Sonnet, and Georges Fournier
January 2011, Pediatric endocrinology, diabetes, and metabolism,
Copied contents to your clipboard!